Press
releases

Apr 27, 2023

Ultragenyx to Host Conference Call for First Quarter 2023 Financial Results and Corporate Update

Read more
Apr 19, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more
Mar 28, 2023

Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

Read more
Mar 21, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more
Mar 14, 2023

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Read more
Feb 28, 2023

Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference

Read more
Feb 16, 2023

Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

Read more
Feb 09, 2023

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update

Read more
Jan 06, 2023

Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones

Read more
Jan 04, 2023

Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference

Read more
Sign up for Email Alerts
Email Alerts Sign-up